KRAS mutated lung adenocarcinoma responds to pan-ERBB and Aurora kinase inhibitors. [PDF]
Uras IZ +9 more
europepmc +1 more source
The ErbB-tyrosine kinase inhibitor, neratinib, has anti-inflammatory effects in multimorbidity by increasing macrophage efferocytosis via the upregulation of MerTK. [PDF]
Bowden KA +7 more
europepmc +1 more source
Correction to "L-Arginine Activates the Neuregulin-1/ErbB Receptor Signaling Pathway and Increases Utrophin mRNA Levels in C2C12 Cells". [PDF]
europepmc +1 more source
The Epidermal Growth Factor Receptor (EGFR) as a means of neuro-immune cross-conversation. [PDF]
Gryksa K +4 more
europepmc +1 more source
Shaping Cell Identity: Global Transcriptome and Pathway Shifts during Mouse Mammary Epithelial Cell Differentiation. [PDF]
Ahmad W +3 more
europepmc +1 more source
Exploring the mechanism of action of Kaixin San in treating dementia based on network pharmacology and molecular docking. [PDF]
Liu S, Zhang Z.
europepmc +1 more source
Plasticity, injury-induced reprogramming, and translational applications of Schwann cells in neural regeneration. [PDF]
Zhu Y +5 more
europepmc +1 more source
ErbB Receptor Feedback Inhibitor 1 Mutation in Biliary Tract Cancers: Turning Resistance Into Response. [PDF]
Peshin S +10 more
europepmc +1 more source
A review of epidermal growth factor receptor ligands in glucose homeostasis. [PDF]
Chan KY +5 more
europepmc +1 more source

